The lung in diabetes - Yet another target organ?

Chronic Respiratory Disease

Volumn 5, Issue 2, 2008, Pages 67-68

  Kuitert, L M E ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN; ORAL ANTIDIABETIC AGENT;

AUTONOMIC NEUROPATHY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC OBESITY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSPNEA; EDITORIAL; FORCED EXPIRATORY VOLUME; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LUNG ALVEOLUS CELL TYPE 2; LUNG BLOOD VESSEL; LUNG COMPLICATION; LUNG DISEASE; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG VOLUME; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; DIABETES MELLITUS; DISEASE COURSE; LUNG; NOTE; PATHOPHYSIOLOGY;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG DISEASES;

EID: 53449092392     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972308091408     Document Type: Editorial

References (11)

1. http://www.diabetes.org/diabetes-statistics.jsp (accessed 24.02.08).
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329: 977 - 986.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998 ; 352: 837 - 853.
4. Kaparianos A, Argyropoulou E, Sampsonas F, et al. Pulmonary complications in diabetes mellitus.. Chron Respir Dis 2008; 5: 101-108.
5. Lange P Parner J Schnohr P Jensen G. Copenhagen City Heart Study: Longitudinal analysis of ventilatory capacity in diabetic and non-diabetic adults. Eur Respir J 2002 ; 20: 1406 - 1412.
6. Skyler JS Jovanovic L Reis J Duggan W. for the Inhaled Human Insulin type 1 Diabetes Study Group. 2 year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care 2007 ; 30: 579 - 585.
7. Barnett AH Lange P Dreyer M Serdarevic-Pehar M. on behalf of the Exubera phase 3 study group. Long term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Int J Clin Pract 2007 ; 61: 1614 - 1625.
8. Niranjan V McBrayer DG Ramirez LC Raskin P Hsia CCW. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med 1997 ; 103: 504 - 513.
9. Guazzi M Oreglia I Guazzi MD. Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes. Diabetes Care 2002 ; 25: 1802 - 1806.
10. Antonelli Incalzi R Fuso L Pitocco D Basso S Trove A Longobardi A. Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study. Diabetes Metab Res Rev 2007 ; 23: 311 - 316.
11. Andersen H Schmitz O Nielsen S. Decreased isometric muscle strength after acute hyperglycemia in type 1 diabetic patients. Diabet Med 2005 ; 22: 1401 - 1407.